Benzodiazepine Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026

Published on : Jan-2020 | List of Tables : 30 | List of Figures : 93 | No. of Pages : 170 | Report Code : FACT4432MR | Format :

High-volume Yet Low-value Sales Projected in Benzodiazepine Drugs Market

Branded medications such as Xanax continue to witness a diminishing impact in the benzodiazepine drugs market, on the back of growing popularity of generic drugs. High capital requirements for the development of quality branded drugs are increasing the penetration of generic drugs in the benzodiazepine drugs market. The trend of developing generic drugs holds relevance for prominent players such as Teva Pharmaceutical Industries Ltd. and Mylan N.V., who generate a sizeable revenue (around 58% market share) through the sales of generic products.

Benzodiazepine drugs are a single panacea to numerous disorders such as anxiety, insomnia, and seizures, which continues to catalyse sales through multiple applications. Growing awareness about the side-effects of psychoactive drugs, in turn, increases the adoption of relatively safe benzodiazepine drugs.

Considering the relevance of these crucial dynamics, a comprehensive study by Fact.MR opines that, demand for benzodiazepine drugs would remain high-albeit generic ones-which would drive voluminous sales, though contribute moderately to market value. That being said, the benzodiazepine drugs market is expected to record a pedestrian CAGR of around 2.7% during the forecast period (2020-2026).

analysis of benzodiazepine drugs market by application

For detailed insights on market taxonomy, request a sample copy of the report here.

Drug Abuse and Reported Cases of Death Associated with Benzodiazepine Drugs to Hamper Revenue Potential of Market

A cohort of factors such as increasing benzodiazepine drug abuse and several reported cases of overdose leading to death, apart from increase in popularity of generic drugs, is resulting in sluggish growth of the market. These drugs produce a calming effect, which leads to drug abuse, and, in turn, increases drug dependency.

Long-term consumption of benzodiazepine drugs is found to cause breathing problems, dizziness, weakness, tremors, pneumonia, brain damage, and in extreme cases, can also lead to death. According to the National Institute on Drug Abuse, the year 2017 witnessed around 11,537 deaths caused by the overdose of benzodiazepine drugs. In response to such incidence, various government bodies now regulate prescription of the drug, further hampering market growth.

assessment of lucrative opportunity in benzodiazepine drugs market by time of action

For detailed regional analysis, request a sample copy of the report here.

North American Benzodiazepine Drugs Market Growing in Proportion to Increasing Prevalence of Anxiety Disorders

North America is a key benzodiazepine drugs market, with high consumption of these drugs for the treatment of anxiety disorders. According to the Anxiety and Depression Association, anxiety disorders affect around 40 million adults in the U.S., every year, which is likely to increase adoption, as consciousness regarding quality treatment grows among individuals.

Application of benzodiazepine drugs for the treatment of anxiety alone is projected to account for over 53% share in the market by 2026, while drug consumption for the treatment of seizures is likely to record a CAGR of around 2.4% during the forecast period. However, the impact of stringent regulations against drug abuse is such that, sales of benzodiazepine drugs receive closure through retail and hospital pharmacies, as these drugs require a proper prescription. This, when compared to relatively lenient regulations in Asia Pacific and Latin America, sales of benzodiazepine drugs through online pharmacies are projected to witness a CAGR of around 3.5% and 3.4%, respectively.

Benzodiazepine Drugs Market – Scope of the Study

The report on the benzodiazepine drugs market is an exclusive study, which has been recently added to the broad report repository of Fact.MR. This study brings to the fore crucial aspects that have been influencing the growth of the benzodiazepine drugs market. This comprehensive study offers analytical insights pertaining to the recent developments in the benzodiazepine drugs market, through the analysis of historical data for the period of 2016-2019, with the duration of 2020-2026 considered as the forecast period.

Recalibration of revenue of the benzodiazepine drugs market has been carried out in terms of value (US$ Mn). This research report offers exclusive insights into the influential trends that hold high potential to shape the benzodiazepine drugs market during the forecast period. Besides this, the report also includes numerous macroeconomic and microeconomic growth indicators that support the growth of the benzodiazepine drugs market during the forecast period. This detailed guide offers crucial information into key dynamics, along with their influence on the benzodiazepine drugs market during the forecast period.

The detailed report, in turn, brings to the fore, insightful information about key challenges and threats that could limit the growth potential of players in the benzodiazepine drugs market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global benzodiazepine drugs market. With a view to aid stakeholders in the benzodiazepine drugs market, the study comprises a detailed section on the competition analysis.

This exclusive study offers a dashboard view of the benzodiazepine drugs market, with detailed information about market players, based on overall revenue, key developments, and their market presence. Additionally, key strategies of players in the benzodiazepine drugs market have also been included in this comprehensive study.

Benzodiazepine Drugs Market – Assessment of Key Segments

Authors of this comprehensive research have classified the benzodiazepine drugs market into key segments for an in-depth study of the market. Categorisation of the benzodiazepine drugs market is based on distribution channel, time of action, application, product, and region. This detailed study also offers information about the incremental opportunity present in the benzodiazepine drugs market during the forecast period. Key segments considered while studying the benzodiazepine drugs market include:

Distribution Channel

Time of Action

Application

Product

Region

Hospital Pharmacies

Ultra-short Acting

Anxiety

Alprazolam

North America

Retail Pharmacies

Short Acting

Seizures

Clonazepam

Europe

Others

Long Acting

Insomnia

Diazepam

Asia Pacific

 

 

Alcohol Withdrawal

Lorazepam

Latin America

 

 

Others

Others

Middle East & Africa

Revenue of the benzodiazepine drugs market has been estimated in terms of US$ Mn for the period of 2020-2026. In addition to this, compound annual growth rate (CAGR %) has been estimated for all segments during the forecast period of 2020-2026, considering 2019 as the base year, in the benzodiazepine drugs market.

Analysts of the report have analysed the profiles of leading, prominent, and emerging players in the benzodiazepine drugs market, in order to obtain a detailed idea regarding the competition prevailing in the landscape. Key players profiled in this comprehensive study include Aurobindo Pharma, Pfizer Inc., Apotex Inc., F.Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Inc., Amneal Pharmaceuticals LLC, H.Lundbeck A/S, Mylan N.V., and Teva Pharmaceutical Industries Ltd.

Benzodiazepine Drugs Market – Research Methodology

The primary objective of this exclusive study on the benzodiazepine drugs market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2026. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the benzodiazepine drugs market, and the adoption rate of benzodiazepine drugs in key regions across the world. Top-down and bottom-up approaches have also been adopted by research analysts in order to validate data and statistics to offer accurate market information to stakeholders.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Benzodiazepine Drugs Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Benzodiazepine Drugs Market Analysis and Forecast, 2020–2026

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Regulatory Scenario by Region/globally

    5.2. Pipeline Analysis

    5.3. Overview of Growing Benzodiazepine Drug Misuse

6. Global Benzodiazepine Drugs Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Benzodiazepine Drugs Market Value Forecast, by Product, 2020–2026

        6.3.1. Alprazolam

        6.3.2. Clonazepam

        6.3.3. Diazepam

        6.3.4. Lorazepam

        6.3.5. Others

    6.4. Global Benzodiazepine Drugs Market Attractiveness, by Product 

7. Global Benzodiazepine Drugs Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Benzodiazepine Drugs Market Value Forecast, by Application, 2020–2026

        7.3.1. Anxiety

        7.3.2. Insomnia

        7.3.3. Alcohol Withdrawal

        7.3.4. Seizures

        7.3.5. Others

    7.4. Global Benzodiazepine Drugs Market Attractiveness, by  Application 

8. Global Benzodiazepine Drugs Market Analysis and Forecast, by Time of Action

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2020–2026

        8.3.1. Ultra-short Acting

        8.3.2. Short Acting

        8.3.3. Long Acting

    8.4. Global Benzodiazepine Drugs Market Attractiveness, by Time of Action

9. Global Benzodiazepine Drugs Market Analysis and Forecast, by Distribution Channel

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Global Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2020–2026

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Others

    9.4. Global Benzodiazepine Drugs Market Attractiveness, by Distribution Channel

10. Global Benzodiazepine Drugs Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Global Benzodiazepine Drugs Market Value Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East and Africa 

    10.3. Global Benzodiazepine Drugs Market Attractiveness, by Region

11. North America Benzodiazepine Drugs Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. North America Benzodiazepine Drugs Market Value Forecast, by Product, 2020–2026

        11.2.1. Alprazolam

        11.2.2. Clonazepam

        11.2.3. Diazepam

        11.2.4. Lorazepam

        11.2.5. Others

    11.3. North America Benzodiazepine Drugs Market Value Forecast, by Application, 2020–2026

        11.3.1. Anxiety

        11.3.2. Insomnia

        11.3.3. Alcohol Withdrawal

        11.3.4. Seizures

        11.3.5. Others

    11.4. North America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2020–2026

        11.4.1. Ultra-short Acting

        11.4.2. Short Acting

        11.4.3. Long Acting

    11.5. North America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2020–2026

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Others

    11.6. North America Benzodiazepine Drugs Market Value Forecast, by Country, 2020–2026

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Benzodiazepine Drugs Market Attractiveness Analysis 

        11.7.1. By Product 

        11.7.2. By Application 

        11.7.3. By Time of Action

        11.7.4. By Distribution Channel

        11.7.5. By Country

12. Europe Benzodiazepine Drugs Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Benzodiazepine Drugs Market Value Forecast, by Product, 2020–2026

        12.2.1. Alprazolam

        12.2.2. Clonazepam

        12.2.3. Diazepam

        12.2.4. Lorazepam

        12.2.5. Others

    12.3. Europe Benzodiazepine Drugs Market Value Forecast, by Application, 2020–2026

        12.3.1. Anxiety

        12.3.2. Insomnia

        12.3.3. Alcohol Withdrawal

        12.3.4. Seizures

        12.3.5. Others

    12.4. Europe Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2020–2026

        12.4.1. Ultra-short Acting

        12.4.2. Short Acting

        12.4.3. Long Acting

    12.5. Europe Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2020–2026

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Others

    12.6. Europe Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2020–2026

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Italy

        12.6.5. Spain

        12.6.6. Rest of Europe 

    12.7. Europe Benzodiazepine Drugs Market Attractiveness Analysis 

        12.7.1. By  Product 

        12.7.2. By Application 

        12.7.3. By Time of Action

        12.7.4. By Distribution Channel

        12.7.5. By Country/Sub-region

13. Asia Pacific Benzodiazepine Drugs Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Product, 2020–2026

        13.2.1. Alprazolam

        13.2.2. Clonazepam

        13.2.3. Diazepam

        13.2.4. Lorazepam

        13.2.5. Others

    13.3. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Application, 2020–2026

        13.3.1. Anxiety

        13.3.2. Insomnia

        13.3.3. Alcohol Withdrawal

        13.3.4. Seizures

        13.3.5. Others

    13.4. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2020–2026

        13.4.1. Ultra-short Acting

        13.4.2. Short Acting

        13.4.3. Long Acting

    13.5. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2020–2026

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Others

    13.6. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2020–2026

        13.6.1. China

        13.6.2. India

        13.6.3. Japan

        13.6.4. Australia & New Zealand

        13.6.5. Rest of APAC

    13.7. Asia Pacific Benzodiazepine Drugs Market Attractiveness Analysis 

        13.7.1. By  Product 

        13.7.2. By Application 

        13.7.3. By Time of Action

        13.7.4. By Distribution Channel

        13.7.5. By Country/Sub-region

14. Latin America Benzodiazepine Drugs Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Latin America Benzodiazepine Drugs Market Value Forecast, by Product, 2020–2026

        14.2.1. Alprazolam

        14.2.2. Clonazepam

        14.2.3. Diazepam

        14.2.4. Lorazepam

        14.2.5. Others

    14.3. Latin America Benzodiazepine Drugs Market Value Forecast, by Application, 2020–2026

        14.3.1. Anxiety

        14.3.2. Insomnia

        14.3.3. Alcohol Withdrawal

        14.3.4. Seizures

        14.3.5. Others

    14.4. Latin America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2020–2026

        14.4.1. Ultra-short Acting

        14.4.2. Short Acting

        14.4.3. Long Acting

    14.5. Latin America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2020–2026

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Others

    14.6. Latin America Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2020–2026

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of LATAM 

    14.7. Latin America Benzodiazepine Drugs Market Attractiveness Analysis 

        14.7.1. By  Product 

        14.7.2. By Application 

        14.7.3. By Time of Action

        14.7.4. By Distribution Channel

        14.7.5. By Country/Sub-region

15. Middle East & Africa Benzodiazepine Drugs Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Product, 2020–2026

        15.2.1. Alprazolam

        15.2.2. Clonazepam

        15.2.3. Diazepam

        15.2.4. Lorazepam

        15.2.5. Others

    15.3. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Application, 2020–2026

        15.3.1. Anxiety

        15.3.2. Insomnia

        15.3.3. Alcohol Withdrawal

        15.3.4. Seizures

        15.3.5. Others

    15.4. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2020–2026

        15.4.1. Ultra-short Acting

        15.4.2. Short Acting

        15.4.3. Long Acting

    15.5. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2020–2026

        15.5.1. Hospital Pharmacies

        15.5.2. Retail Pharmacies

        15.5.3. Others

    15.6. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2020–2026

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of MEA

    15.7. Middle East & Africa Benzodiazepine Drugs Market Attractiveness Analysis 

        15.7.1. By  Product 

        15.7.2. By Application 

        15.7.3. By Time of Action

        15.7.4. By Distribution Channel

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (By Tier and Size of companies)

    16.2. Market Share Analysis By Tier and Size of the Company (2019)

    16.3. Company Profiles

        16.3.1. Pfizer Inc.

        16.3.2. F.Hoffmann-La Roche Ltd.

        16.3.3. Bausch Health Companies, Inc.

        16.3.4. Mylan N.V. 

        16.3.5. Teva Pharmaceutical Industries Ltd. 

        16.3.6. H.Lundbeck A/S 

        16.3.7. Amneal Pharmaceuticals LLC 

        16.3.8. Sun Pharmaceutical Industries Ltd.

        16.3.9. Apotex Inc. 

        16.3.10. Aurobindo Pharma

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benzodiazepine Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026